Fahad Lwigale

Mr. Fahad Lwigale

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2024 in Wellcome Open Research
Verified
Journal Article
Open access
HMHope Mackline
Hope Mackline
RKReuben Kiggundu
Reuben Kiggundu
DTDickson Tabajjwa
Dickson Tabajjwa
CTConrad Tumwine
Conrad Tumwine
FLFahad Lwigale
Fahad Lwigale
AKAndrew Kambugu
Andrew Kambugu
Introduction The World Health Organization global antimicrobial resistance surveillance system (GLASS) was rolled out in 2015 to guide antimicrobial resistance (AMR) surveillance. However, its implementation in Africa has not been fully evaluated. We conducted a scoping review to establish the progress of implementing the WHO 2015 GLASS manual in Africa. Methods We used MeSH terms to comprehensively search electronic databases (MEDLINE and Embase) for articles from Africa published in English between January 2016 and December 2023. The Arksey and O'Malley's methodological framework for scoping reviews was employed. Data were collected on compliance with WHO GLASS recommendations for AMR surveillance-priority samples, pathogens, and pathogen-antibiotic combinations and analysed using Microsoft Excel. Results Overall, 13,185 articles were identified. 7,409 were duplicates, and 5,141 articles were excluded based on titles and abstracts. 609 full-text articles were reviewed, and 147 were selected for data extraction. Of the 147 selected articles, 78.9% had been published between 2020 and 2023; 57.8% were from Eastern Africa. 93.9% of articles were on cross-sectional studies. 96.6% included only one priority sample type; blood (n=56), urine (n=64), and stool (n=22). Of the 60 articles that focused on blood as a priority sample type, 71.7%, 68.3%, 68.3%, 36.7%, 30%, and 10% reported recovery of Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Salmonella species and Streptococcus pneumoniae, respectively. Salmonella and Shigella species were reported to have been recovered from 91.3% and 73.9% of the 23 articles that focused on stool. E. coli and K. pneumoniae recoveries were also reported from 94.2% and 68.1% of the 69 articles that focused on urine. No article in this review reported having tested all the recommended WHO GLASS pathogen-antibiotic combinations for specific pathogens. Conclusion Progress has been made in implementing the GLASS recommendations in Africa, but adoption varies across countries limiting standardisation and comparability of data.

2 August 2024 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
FLFahad Lwigale
Fahad Lwigale
DKDaniel Kibombo
Daniel Kibombo
SKSimon Dembe Kasango
Simon Dembe Kasango
DTDickson Tabajjwa
Dickson Tabajjwa
CACollins Atuheire
Collins Atuheire
IRInnocent B. Rwego
Innocent B. Rwego
Skin and soft-tissue infections (SSTI) are common cases of hospital-acquired infections with aetiological agents exhibiting antimicrobial resistance (AMR). This is a global public health predicament responsible for a high burden of infectious diseases and threatens the achievement of Sustainable Development Goals (SDGs), especially in Low- and Middle-Income countries (LMICs). This study determined the prevalence of SSTI, proportion of laboratory-investigated cases, AMR-profiles, and factors associated with SSTI and multi-drug resistance (MDR). This was based on records of patients suspected of SSTI for the period of 2019–2021 at Jinja Regional Referral Hospital. The analysis involved 268 randomly selected patient reports using WHONET 2022 and Stata 17 at the 95% confidence level. The prevalence of SSTI was 66.4%. Cases that involved laboratory testing were 14.1%. Staphylococcus aureus (n = 51) was the most isolated organism. MDR pathogens explained 47% of infections. Methicillin-resistant Staphylococcus aureus (MRSA) was up to 44%. In addition, 61% of Gram-negatives had the potential to produce extended-spectrum beta-lactamases (ESBL), while 27% were non-susceptible to carbapenems. Ward of admission was significantly associated with infection (aPR = 1.78, 95% CI: 1.00–3.18, p-value = 0.04). Age category (19–35) was an independent predictor for MDR infections (aPR = 2.30, 95%CI:1.02–5.23, p-value = 0.04). The prevalence of SSTI is high with MDR pathogens responsible for almost half of the infections. Gentamicin and ciprofloxacin can be considered for empirical management of strictly emergency SSTI cases suspected of Staphylococcus aureus. Given the high resistance observed, laboratory-based diagnosis should be increased to use the most appropriate treatment. Infection Prevention and Control (IPC) strategies should be heightened to reduce the prevalence of SSTI. Recognizing SSTI under the Global Antimicrobial resistance Surveillance System (GLASS) would lead to improved preparedness and response to AMR.

15 November 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
HMHope Mackline
Hope Mackline
RKReuben Kiggundu
Reuben Kiggundu
DBDathan Byonanebye
Dathan Byonanebye
JMJonathan Mayito
Jonathan Mayito
DTDickson Tabajjwa
Dickson Tabajjwa
FKFrancis Kakooza
Francis Kakooza
Background: Antimicrobial resistance (AMR) is a major global public health concern, particularly in low- and middle-income countries where resources and infrastructure for an adequate response are limited. The World Health Organization (WHO) Global Antimicrobial Resistance Surveillance System (GLASS) was introduced in 2016 to address these challenges, outlining recommendations for priority pathogen-antibiotic combinations. Despite this initiative, implementation in Africa remains understudied. This scoping review aims to assess the current state of implementing WHO GLASS recommendations on antimicrobial sensitivity testing (AST) in Africa. Objective: The primary objective of this study is to determine the current state of implementing the WHO GLASS recommendations on AST for priority pathogen-antimicrobial combinations. The review will further document if the reporting of AST results is according to “susceptible,” “intermediate,” and “resistant” recommendations according to GLASS. Methods: Following the methodological framework by Arksey and O’Malley, studies published between January 2016 and November 2023 will be included. Search strategies will target electronic databases, including MEDLINE, Scopus, CINAHL, and Embase. Eligible studies will document isolates tested for antimicrobial sensitivity, focusing on WHO-priority specimens and pathogens. Data extraction will focus on key study characteristics, study context, population, and adherence to WHO GLASS recommendations on AST. Descriptive statistics involving summarizing the quantitative data extracted through measures of central tendency and variation will be used. Covidence and Microsoft Excel software will be used. This study will systematically identify, collate, and analyze relevant studies and data sources based on clear inclusion criteria to provide a clear picture of the progress achieved in the implementation of the WHO GLASS recommendations. Areas for further improvement will be documented to inform future efforts to strengthen GLASS implementation for enhanced AMR surveillance in Africa. Results: The study results are expected in August 2024. Conclusions: To our knowledge, this scoping review will be the first to comprehensively examine the implementation of WHO GLASS recommendations in Africa, shedding light on the challenges and successes of AMR surveillance in the region. Addressing these issues aims to contribute to global efforts to combat AMR. International Registered Report Identifier (IRRID): PRR1-10.2196/58140

10 December 2025 in Wellcome Open Research
Verified
Journal Article
Open access
HMHerman Mwanja
Herman Mwanja
RKReuben Kiggundu
Reuben Kiggundu
RWRichard Walwema
Richard Walwema
FLFahad Lwigale
Fahad Lwigale
JWJp. Waswa
Jp. Waswa
FKFrancis Kakooza
Francis Kakooza
Background Antimicrobial resistance (AMR) poses a critical global health threat, with low- and middle-income countries (LMICs) facing systemic challenges in the detection and response to outbreaks of resistant pathogens. Despite Uganda establishing a national AMR surveillance system, there are no systems for the real-time detection of AMR outbreaks due to limited laboratory capacity, standardised protocols and data management systems. Methods This study involved a retrospective analysis of blood culture data collected from ten sentinel AMR surveillance sites (tertiary hospitals) across Uganda between October 2020 and December 2023 to evaluate AMR patterns, identify resistance alerts, and missed AMR outbreaks. Blood culture data from 2,572 patients were analysed using WHONET-SaTScan software to generate isolate listing summaries, identify resistance alerts of public health importance, and detect spatial-temporal clusters that signal potential outbreaks of resistant bacteria. Results Bacterial growth was observed in 17.1% (441/2,572) of blood samples. The key isolated pathogens included Staphylococcus aureus 19.1% (86/441), Coagulase-negative Staphylococci 34.7% (153/441), and Escherichia coli 7.5% (33/441). Critical AMR alerts included 13.6% (60/441) cases of extended-spectrum β-lactamase (ESBL)-producing Enterobacterales and 3.6% (16/441) carbapenem-resistant isolates, alongside high-priority resistance mechanisms such as methicillin-resistant Staphylococcus aureus (15/441) and vancomycin-resistant Enterococci 1.4% (6/441). Spatial-temporal analysis revealed seven significant clusters (possible outbreaks) across three sites, including a 12-day Enterococcus species cluster in a paediatric ward and a multi-ward Staphylococcus aureus outbreak. Conclusions This study reveals a significant burden of drug-resistant bloodstream infections in Ugandan hospitals and shows that key outbreak signals and possible outbreaks went unnoticed. Strengthening surveillance with real-time alerts, better data use, and targeted responses is critical to controlling the spread of resistant bacteria in Uganda and similar settings.

7 March 2024 in JMIR Preprints
Verified
Preprint
Open access
HMHope Mackline
Hope Mackline
RKReuben Kiggundu
Reuben Kiggundu
DBDathan Byonanebye
Dathan Byonanebye
JMJonathan Mayito
Jonathan Mayito
DTDickson Tabajjwa
Dickson Tabajjwa
FKFrancis Kakooza
Francis Kakooza
BACKGROUND Antimicrobial resistance (AMR) is a major global public health concern, particularly in low- and middle-income countries where resources and infrastructure for an adequate response are limited. The World Health Organization (WHO) Global Antimicrobial Resistance Surveillance System (GLASS) was introduced in 2016 to address these challenges, outlining recommendations for priority pathogen-antibiotic combinations. Despite this initiative, implementation in Africa remains understudied. This scoping review aims to assess the current state of implementing WHO GLASS recommendations on antimicrobial sensitivity testing (AST) in Africa. OBJECTIVE The primary objective of this study is to determine the current state of implementing the WHO GLASS recommendations on AST for priority pathogen-antimicrobial combinations. The review will further document if the reporting of AST results is according to “susceptible,” “intermediate,” and “resistant” recommendations according to GLASS. METHODS Following the methodological framework by Arksey and O’Malley, studies published between January 2016 and November 2023 will be included. Search strategies will target electronic databases, including MEDLINE, Scopus, CINAHL, and Embase. Eligible studies will document isolates tested for antimicrobial sensitivity, focusing on WHO-priority specimens and pathogens. Data extraction will focus on key study characteristics, study context, population, and adherence to WHO GLASS recommendations on AST. Descriptive statistics involving summarizing the quantitative data extracted through measures of central tendency and variation will be used. Covidence and Microsoft Excel software will be used. This study will systematically identify, collate, and analyze relevant studies and data sources based on clear inclusion criteria to provide a clear picture of the progress achieved in the implementation of the WHO GLASS recommendations. Areas for further improvement will be documented to inform future efforts to strengthen GLASS implementation for enhanced AMR surveillance in Africa. RESULTS The study results are expected in August 2024. CONCLUSIONS To our knowledge, this scoping review will be the first to comprehensively examine the implementation of WHO GLASS recommendations in Africa, shedding light on the challenges and successes of AMR surveillance in the region. Addressing these issues aims to contribute to global efforts to combat AMR. INTERNATIONAL REGISTERED REPORT PRR1-10.2196/58140

15 August 2023 in medRxiv
Verified
Preprint
Open access
PDF file
FLFahad Lwigale
Fahad Lwigale
Introduction: Bloodstream infections are a commonly encountered clinical syndrome of public health concern with variable epidemiology. The characteristic of resistance to multiple antibiotics by their etiologic agents has limited the options for empirical sepsis case management. This study determined the most frequent aetiologic agents responsible for bloodstream infections, their antimicrobial susceptibility patterns, and infection sources in Eastern-Central Uganda. Materials and methods: This retrospective study involved analysis of all non-duplicate blood culture reports from 2019 to 2021. The frequency and percentage of significant pathogenic organisms and contaminants were calculated. Positivity distribution including infection sources was determined. World Health Organization Network (WHONET) 2022 desktop software was used for antimicrobial susceptibility data analysis. Results: The 1364 participants had a diagnostic yield of 114(6.8%) and a 1.5% contamination rate. Over 37% and 13% of infections were hospital and community-acquired respectively. Most etiologic agents were Gram-positive bacteria dominated by Staphylococcus aureus 39(34.2%). Gram-negatives mainly included unspecified Coliforms 12(10.5%), and E. coli 10(8.8%). Polymicrobial growth existed in 4(0.3%) cases. S. aureus was mainly resistant to Penicillin G (100%), Cefoxitin (60%), and Erythromycin (52.2%). Both Escherichia coli and unspecified coliforms showed high resistance to Ampicillin (87.5%) and third-generation Cephalosporins (100%). The least resistance was to Chloramphenicol and Carbapenems. Conclusion: BSIs are mainly due to Gram-positive bacteria. Suspected sepsis cases by S. aureus in this region can be empirically managed using Gentamicin. Microbiology services should be routinely utilized to guide antimicrobial use, monitor blood culture contamination rates and resistance trends to strengthen regional antimicrobial stewardship.